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Abstract 
Sutures loaded with growth factors or antimicrobials are common place but the release of the 
therapeutic agent is almost invariably achieved through passive release mechanisms. A gold 
microwire loaded with cellulose acetate phthalate encapsulated drug droplets is proposed as an 
alternative design approach. The release mechanism relies upon the imposition of a suitable 
reducing potential at the gold suture resulting in an increase in local pH and thereby induces the 
dissolution of the polymeric binder and releases the drug. The ability to actively control the 
dissolution-release processes could lay the foundations for smart suture design where more 
responsive/metered dosing can be achieved. 
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1.0 Introduction 
 
Sutures are an invaluable tool in the treatment of major wounds where they offer a speedy method 
of binding apposing tissues and, in principle, can facilitate wound healing[1-4]. While the general 
mechanism of wound closure has changed relatively little in recent years, the materials employed in 
the manufacture of sutures have evolved considerably. Biodegradability, physical structure and 
chemical composition are the key factors subject to manipulation and there is a wealth of 
commercially available variants [2,3]. Sutures possessing antimicrobial activity are now 
commonplace and have arisen partly in response to the long standing issues of surgical site infection 
(SSI)[3]. The latter are generally acknowledged as being the most commonly incurred postoperative 
complication and are attributed to 15-20% of all nosocomial infection arising after surgery [5,6]. It 
has been demonstrated that sutures loaded with antimicrobial agents (such as triclosan or silver 
nanoparticles) reduce infection rates and improve wound recovery[2,3,6-10]. Irrespective of design, 
commercial sutures are typically based on a thread-like form to provide the mechanical resilience 
needed to draw the wound edges together and, thereafter, the antimicrobial features are invariably 
delivered through passive interaction with the surrounding tissue[2]. Given the increasing concerns 
over antimicrobial resistance, there is a need for a further improvements in suture design where the 
latter is capable of providing a more active role – either through providing diagnostic telemetry of 
the healing dynamics or enabling the targeted delivery of drugs to the site of infection. The aim of 
the present communication is to evaluate the use of a gold-silver composite thread as a platform 
through which electronic sutures capable of controlling the release of a chemical agent could be 
developed. 
Kim and Colleagues (2012) demonstrated a microfabricated strip sensor capable of sensory feedback 
and actuation and have heralded a step change in suture design[11]. The present investigation has 
similarly sought to explore the controlled actuation through a potentially simpler, though more 
versatile and easily implemented electrochemical route. The rationale revolves around the 
encapsulation of the model drug (Toluidine Blue O, TBO) within cellulose acetate phthalate (CAP) 
droplets which are dispersed along the length a gold micro wire (25-100 m diameter) as indicated 
in Figure 1.  The CAP polymer binder is pH sensitive and is extensively used in oral tablet 
formulations to enable delivery of drug to the intestine where the alkaline environment dissolves 
the protective coating[11-16]. Thus, it was envisaged that upon the imposition of a suitably reducing 
potential (-1V to -2V) at the gold electrode, the local pH is increased and the CAP droplets should 
dissolve and thereby release the drug[17].  
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The wire itself lacks the necessary tensile strength to pull the wound surfaces together but can be 
incorporated as an additional component within a conventional suture thread. A commercial silver 
thread is employed as both the structural suture backbone and second electrode in the 
electrochemical design.  This report examines the electrochemical behaviour of the various 
components and assesses the efficacy of the proposed mechanism.  
2.0 Experimental Details 
Electrochemical measurements were conducted using a Autolab computer controlled potentiostat 
(Eco-Chemie, Utrecht, The Netherlands). All measurements were conducted at 22oC ± 2oC in Britton 
Robinson buffer (pH 3-10) unless stated otherwise. Gold and Silver wires were supplied by 
Goodfellow Ltd.  In cases where a three electrode configuration was employed, a silver/silver 
chloride half cell (3 M NaCl, BAS Technicol) served as the reference. Conductive silver thread (0.4 
cm) was supplied by Kitronik Ltd (Nottingham UK). The thread is composed of 96 individual 
filaments, each coated with a micron-thick layer of silver. The fabrication process involves a primary 
twist comprising 16 filaments of cotton. Two primary twists are subsequently wound together to 
form the secondary twist and finally three of the latter are combined to yield the final thread 
consisting of 96 filaments and is approximately 18 denier. The Toluidine Blue O (5 wt%) was mixed 
with the CAP polymer through dissolution in acetonitrile and then dropped and spread along the 
length of the gold wire. While it was initially anticipated that application of the TBO/CAP mixture to 
the gold would have led to a coherent film, the polymer spontaneously coalesced into discrete 
droplets along the length of the wire as a consequence of surface poor wetting. This coating process 
was repeated up to 4 times to increase the yield of TBO. Electrochemical release was induced 
through holding the potential at -1,-1.5,-1.75 or -2V for a given period (typically 10s) and then 
recording the absorbance spectrum (200-800 nm) in a 1cm3 volume cuvette.   
3.0 Results and Discussion 
The efficacy of employing cellulose acetate phthalate as the controlled release polymer was briefly 
assessed using gelatin as the simulated tissue matrix. Toluidine Blue O was used as a model drug as 
its release could be readily monitored through visual inspection (max = 591 nm, = 2.98 x 103 L-1 
mol cm-1) or, as detailed later, through uv-vis spectroscopy. The thread was initially washed to 
remove interfacial TBO such that only the dye encapsulated within the polymer matrix remained.  
The thread was then immersed in gelatin samples whose pH had been previously adjusted and left 
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for up to 48 hours. The results of the study are highlighted in Figures 2 A->F where it can be seen 
that the TBO only emerges when the pH is alkaline. Dissolution of the cap was found to be extremely 
slow from neutral or mildly alkaline (pH 8) with diffusion of the TBO into the surrounding gelatin 
observed after only 48 hours.  
The CAP/TBO droplets positioned on the gold wire (100 m) are shown in Figure 2G though their 
relative positioning is exaggerated for clarity. The structure of the conductive thread is highlighted in 
Figure 2H and it can be seen that, while silver coats each of the individual fibres within the braid, 
there are sections where the underlying cotton is exposed. This is consistent with previous reports of 
electroless deposition of silver on fabrics and can be expected where the plating solution has failed 
to nucleate on particular areas or where the braiding has prevented sufficient penetration[18-20]. 
Nevertheless, the silver deposition clearly extends along the length of the thread and is sufficiently 
coherent to retain conductivity when twisted or sewn which is ideal for the proposed application. It 
should be noted that the prime rationale for the commercialisation of the thread was targeted at 
emerging ‘e-fabric’ and wearable electronics and designed specifically for sewn and woven 
applications. The ability of the thread to serve as a viable reference/counter electrode was assessed 
through comparing the potentiometric response to chloride ion whereby a Nernstian response (-59 
mV) was obtained The tensile strength of the conductive thread was investigated and found to be 
1.6 N/Tex (%RSD = 9.1; N = 6) which compared well with conventional Vicryl® braided suture (0.57 
N/Tex) [21].  Thus it could be expected that the electronic thread would provide the necessary 
strength to draw the apposing wound surfaces together and enable closure.  
A cyclic voltammogram detailing the response of a gold microwire (50 m diameter) towards 
ferrocyanide (2 mM, 0.1 M KCl) using a conventional three electrode system with a 3M NaCl half cell 
and platinum counter electrode is detailed in Figure 3. The voltammetric response produces a 
sigmoidal profile characteristic of microelectrode behaviour as anticipated given the small 
dimensions of the gold wire. Upon switching the cell configuration to a two electrode system in 
which the silver thread is employed as both reference and counter electrode, the voltammetric 
profile was found to retain the same shape but has shifted to less positive potentials. The latter can 
be attributed to the fact that the thread is responding to the bulk chloride concentration (0.1 M KCl) 
rather than the local concentration inherent to the 3M internal solution in the half cell.  
It is clear that the silver thread could be used as a versatile reference-counter electrode with the 
silver deposit providing an extremely large surface area in comparison to the gold wire working 
electrode. The dependence on the chloride concentration within the sample could be an issue when 
considering the use of the thread within a sensing scenario where variations in the former could lead 
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to ambiguities in ascribing peak positions. It is likely however that the homeostatic regulation of 
chloride within the tissues (typically 0.1 M) would reduce magnitude of any peak shift. It must be 
noted however that the drug release actuation proposed here employs large negative potentials 
that are unlikely to be influenced by minor shifts in the reference potential. 
Electrochemical release 
The electrode (suture) assembly was placed in a small volume cuvette and the potential held at 
various reducing potentials and the consequent release of the TBO into the solution monitored 
through uv-spectroscopic analysis. The resulting spectra for the application of the -1.75V   are shown 
in Figure 4A with a quantitative analysis of the drug yield per 10s cycle shown in Figure 4B. The TBO 
absorption peak (591 nm) increases with each application of the reducing potential giving a 
relatively linear response in the initial phases with each 10 second cycle releasing about 2 g of the 
TBO. The latter will obviously be highly dependent on the processing of the suture (Figure 4B Inset) 
and the loading of the drug and, as expected, there is a fair degree of variability between runs given 
the preliminary nature of manufacture described here. 
It is clear from Figure 4B that the release of the TBO can be achieved through the electrochemical 
control of the suture potential. The magnitude of the latter is necessarily large to effect a relatively 
quick dissolution of the polymeric binder but it can be expected that this could be attenuated 
through using less harsh negative potentials. The main criteria is that the potential is sufficient to 
evoke the hydrogen evolution[17]. In our experiments the application of -1V for example was found 
to be too slow to induce dissolution of the CAP release the TBO.   Controlling the time through which 
the potential is applied is another option.  
4.0 Conclusions 
The core advantage of the system presented here lies in the ability to meter the dosing of the model 
drug through inducing a change in the local pH. It must also be recognised that the latter only 
persists while the electrode potential is maintained and that the natural buffer components within 
of the matrix will quickly act to restore the pH to that of the bulk. In doing so, the release process is 
only momentary and will terminate upon removal of the reducing potential.  There is however one 
caveat to the adoption of the technique in that it is important that the drug itself does not contain 
any reducible functionality (i.e. nitro groups) which may be inadvertently reduced whilst imposing 
the reducing potential. While more rigorous means of manufacture would improve the 
reproducibility of delivery, it is evident that the approach provides a versatile platform through 
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which manipulation of either the magnitude of the potential or the duration over which it is applied 
can easily control the release process.  
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Figure 1. Proposed controlled release methodology 
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Figure 2. Release of Toluidine Blue O from Cellulose Acetate Polymer Coating on thread immersed in gelatin of varying pH 
(A-F). (G) Gold microwire (100 m) modified with CAP/TBO droplets. (H) Electron micrograph of the silver suture thread.   
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Figure 3. Cyclic voltammograms detailing the response of a gold wire (50 m) towards 
ferrocyanide (2 mM, 0.1 M KCl, 5 mV/s) using  three electrode (solid line) and two electrode (dashed line) configurations. 
Silver thread was used as the combined reference-counter in the two electrode (prototype suture) investigation.  
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Figure 4. A) Spectra detailing the release of TBO after successive applications of a reducing potential (-1.75V for 10s 
increments) from a 5 cm length of 100 m CAP coated gold wire. B) Yield of drug (g) per 10s reduction cycle. Inset: Typical 
yield per length of suture depending on coating. 
 
